Haemonetics: Pay

Haemonetics paid its 6 named executives $22.7M in total in FY2023 (Apr). CEO Christopher A. Simon was paid $10.7M of that.

PayNo stock prices for these years

CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Christopher A. SimonPresident and Chief Executive Officer


FY2023 (Apr)
FY2022 (Apr)							Not disclosed
FY2021 (Apr)							Not disclosed

3 years

James C. D'AreccaExecutive Vice President, Chief Financial Officer


FY2023 (Apr)
FY2022 (Apr)							Not disclosed

2 years

Michelle L. BasilExecutive Vice President, General Counsel


FY2023 (Apr)
FY2022 (Apr)							Not disclosed
FY2021 (Apr)							Not disclosed

3 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.